The Artificial Intelligence In Cancer Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the global artificial intelligence in cancer diagnostics market has seen significant growth recently. It is projected to increase from $0.39 billion in 2024 to $0.52 billion in 2025, representing a Compound Annual Growth Rate (CAGR) of 32.6%.
The artificial intelligence in cancer diagnostics market is predicted to reach a value of $1.55 billion in 2029, growing at a compound annual growth rate (CAGR) of 31.2%.
Download Your Free Sample of the 2025 Artificial Intelligence In Cancer Diagnostics Market Report and Uncover Key Trends Now!The key drivers in the artificial intelligence in cancer diagnostics market are:
• Rising clinician shortages and an ageing population
• Broad adoption of telemedicine globally
• Integration of artificial intelligence with electronic health records
• Proliferation of cancer screening programs
The artificial intelligence in cancer diagnostics market covered in this report is segmented –
1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types
3) By Application: Screening And Diagnosis, Tumor Identification, Surveillance, Treatment
4) By End-User: Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization
The key trends in the artificial intelligence in cancer diagnostics market are:
• Rapid advances in AI algorithms are an emerging trend shaping the market.
• Advancements in imaging technology are becoming increasingly influential.
• Technological innovations in pathology mark a significant trend.
• Developments in radiomics, radiogenomics, drug development, deep learning, and AI for predictive biomarker discovery are other notable trends.
The major players in the artificial intelligence in cancer diagnostics market are:
• Microsoft Corporation
• Pfizer Inc
North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024